Quest Diagnostic Stock is Ready to Move Higher
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been performing relatively stronger than the benchmark indices down only (-20%) on the year. The Company was a benefactor of the pandemic processing COVID test results, but volumes are falling as COVID wanes amidst mass vaccinations and boosters. PCR testing accounted for nearly $600 million […]